Molecular analysis of sarcoidosis granulomas reveals antimicrobial targets

American Journal of Respiratory Cell and Molecular Biology

Volumn 55, Issue 1, 2016, Pages 128-134

  Rotsinger, Joseph E ^a   Celada, Lindsay J ^a   Polosukhin, Vasiliy V ^b   Atkinson, James B ^a   Drake, Wonder P ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Azithromycin; Ethambutol; Levofloxacin; Rifampin; Sarcoidosis

Indexed keywords

ANTIINFECTIVE AGENT; CYCLOPHILIN B; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE (ATP HYDROLYSING) A; RNA POLYMERASE BETA SUBUNIT; BACTERIAL DNA;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; BERYLLIOSIS; BILE DUCT CARCINOMA; BLASTOMYCOSIS; CELL WALL; CHRONIC BERYLLIUM DISEASE; CHRONIC GRANULOMATOUS DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE CONTROL; DNA SYNTHESIS; FEMALE; GENETIC CODE; GRANULOMATOSIS; HISTOPLASMOSIS; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERSTITIAL PNEUMONIA; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; MICROBIAL GENE; MYCOBACTERIUM TUBERCULOSIS; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SARCOIDOSIS; SQUAMOUS CELL CARCINOMA; STAPHYLOCOCCUS AUREUS; CASE CONTROL STUDY; DEMOGRAPHY; DRUG EFFECTS; GRANULOMA; MICROBIOLOGY; MIDDLE AGED; MOLECULARLY TARGETED THERAPY; MYCOBACTERIUM; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTI-INFECTIVE AGENTS; CASE-CONTROL STUDIES; DEMOGRAPHY; DNA, BACTERIAL; FEMALE; GRANULOMA; HUMANS; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; MOLECULAR TARGETED THERAPY; MYCOBACTERIUM; REAL-TIME POLYMERASE CHAIN REACTION; SARCOIDOSIS; YOUNG ADULT;

EID: 84988937014     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2015-0212OC     Document Type: Article

References (30)

1. Drake WP, Pei Z, Pride DT, Collins RD, Cover TL, Blaser MJ. Molecular analysis of sarcoidosis tissues for mycobacterium species DNA. Emerg Infect Dis 2002;8:1334-1341.
2. Popper HH, Klemen H, Hoefler G, Winter E. Presence of mycobacterial DNA in sarcoidosis. Hum Pathol 1997;28:796-800.
3. Song Z, Marzilli L, Greenlee BM, Chen ES, Silver RF, Askin FB, Teirstein AS, Zhang Y, Cotter RJ, Moller DR. Mycobacterial catalaseperoxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med 2005;201:755-767.
4. Dubaniewicz A, Dubaniewicz-Wybieralska M, Sternau A, Zwolska Z, Izycka-Swieszewska E, Augustynowicz-Kopec E, Skokowski J, Singh M, Zimnoch L. Mycobacterium tuberculosis complex and mycobacterial heat shock proteins in lymph node tissue from patients with pulmonary sarcoidosis. J Clin Microbiol 2006;44:3448-3451.
5. Oswald-Richter KA, Beachboard DC, Zhan X, Gaskill CF, Abraham S, Jenkins C, Culver DA, Drake W. Multiple mycobacterial antigens are targets of the adaptive immune response in pulmonary sarcoidosis. Respir Res 2010;11:161.
6. Oswald-Richter KA, Culver DA, Hawkins C, Hajizadeh R, Abraham S, Shepherd BE, Jenkins CA, Judson MA, Drake WP. Cellular responses to mycobacterial antigens are present in bronchoalveolar lavage fluid used in the diagnosis of sarcoidosis. Infect Immun 2009;77: 3740-3748.
7. Allen SS, Evans W, Carlisle J, Hajizadeh R, Nadaf M, Shepherd BE, Pride DT, Johnson JE, Drake WP. Superoxide dismutase A antigens derived from molecular analysis of sarcoidosis granulomas elicit systemic Th-1 immune responses. Respir Res 2008;9:36.
8. Hajizadeh R, Sato H, Carlisle J, Nadaf MT, Evans W, Shepherd BE, Miller RF, Kalams SA, Drake WP. Mycobacterium tuberculosis antigen 85A induces Th-1 immune responses in systemic sarcoidosis. J Clin Immunol 2007;27:445-454.
9. Drake WP, Dhason MS, Nadaf M, Shepherd BE, Vadivelu S, Hajizadeh R, Newman LS, Kalams SA. Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis. Infect Immun 2007;75:527-530.
10. Chen ES, Wahlström J, Song Z, Willett MH, Wikén M, Yung RC, West EE, McDyer JF, Zhang Y, Eklund A, et al. T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis. J Immunol 2008;181:8784-8796.
11. Drake WP, Oswald-Richter K, Richmond BW, Isom J, Burke VE, Algood H, Braun N, Taylor T, Pandit KV, Aboud C, et al. Oral antimycobacterial therapy in chronic cutaneous sarcoidosis: a randomized, single-masked, placebo-controlled study. JAMA Dermatol 2013;149:1040-1049.
12. Drake W, Richmond BW, Oswald-Richter K, Yu C, Isom JM, Worrell JA, Shipl R. Effects of broad-spectrum antimycobacterial therapy on chronic pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2013;30:201-211.
13. Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du Bois R, Eklund A, Kitaichi M, Lynch J, Rizzato G, et al.; American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and Other Granulomatous Disorders. ATS/ERS/ WASOG statement on sarcoidosis. American Thoracic Society/ European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999;16:149-173.
14. Zheng H, Lu L, Wang B, Pu S, Zhang X, Zhu G, Shi W, Zhang L, Wang H, Wang S, et al. Genetic basis of virulence attenuation revealed by comparative genomic analysis of Mycobacterium tuberculosis strain H37Ra versus H37Rv. PLoS One 2008;3:e2375.
15. Wang F, Flanagan J, Su N, Wang LC, Bui S, Nielson A, Wu X, Vo HT, Ma XJ, Luo Y. RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. J Mol Diagn 2012;14:22-29.
16. Li N, Bajoghli A, Kubba A, Bhawan J. Identification of mycobacterial DNA in cutaneous lesions of sarcoidosis. J Cutan Pathol 1999;26: 271-278.
17. Zechiedrich EL, Khodursky AB, Bachellier S, Schneider R, Chen D, Lilley DM, Cozzarelli NR. Roles of topoisomerases in maintaining steady-state DNA supercoiling in Escherichia coli. J Biol Chem 2000; 275:8103-8113.
18. MikusováK, Slayden RA, Besra GS, Brennan PJ. Biogenesis of the mycobacterial cell wall and the site of action of ethambutol. Antimicrob Agents Chemother 1995;39:2484-2489.
19. Takayama K, Kilburn JO. Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis. Antimicrob Agents Chemother 1989;33:1493-1499.
20. Takayama K, Armstrong EL, Kunugi KA, Kilburn JO. Inhibition by ethambutol of mycolic acid transfer into the cell wall of Mycobacterium smegmatis. Antimicrob Agents Chemother 1979;16: 240-242.
21. Gurvitz A, Hiltunen JK, Kastaniotis AJ. Function of heterologous Mycobacterium tuberculosis InhA, a type 2 fatty acid synthase enzyme involved in extending C20 fatty acids to C60-to-C90 mycolic acids, during de novo lipoic acid synthesis in Saccharomyces cerevisiae. Appl Environ Microbiol 2008;74:5078-5085.
22. Korta DZ, Ochieng P, Fishman D, Katz SE. Pulmonary sarcoidosis and latent tuberculosis in a patient with psoriasis treated with adalimumab. Dermatol Online J 2015;21:21.
23. Mandal SK, Ghosh S, Mondal SS, Chatterjee S. Coexistence of pulmonary tuberculosis and sarcoidosis: a diagnostic dilemma. BMJ Case Rep 2014;2014.
24. Mohapatra PR, Garg K, Singhal N, Aggarwal D, Gupta R, Khurana A, Janmeja AK. Tuberculosis lymphadenitis in a well managed case of sarcoidosis. Indian J Chest Dis Allied Sci 2013;55:217-220.
25. Luetkens JA, Zoghi S, Rockstroh JK, Naehle CP. Pulmonary sarcoidosis shortly after spinal tuberculosis infection: a diagnostic challenge. BMJ Case Rep 2014;2014.
26. Luk A, Lee A, Ahn E, Soor GS, Ross HJ, Butany J. Cardiac sarcoidosis: recurrent disease in a heart transplant patient following pulmonary tuberculosis infection. Can J Cardiol 2010;26:e273-e275.
27. Gupta LK, Luhadia SK, Khare AK, Garg A, Mittal A, Kuldeep CM. Pulmonary and cutaneous sarcoidosis in a treated case of renal tuberculosis. Indian J Dermatol Venereol Leprol 2012;78:229.
28. Mdluli K, Swanson J, Fischer E, Lee RE, Barry CE III. Mechanisms involved in the intrinsic isoniazid resistance of Mycobacterium avium. Mol Microbiol 1998;27:1223-1233.
29. Cosma CL, Humbert O, Sherman DR, Ramakrishnan L. Trafficking of superinfecting mycobacterium organisms into established granulomas occurs in mammals and is independent of the Erp and ESX-1 mycobacterial virulence loci. J Infect Dis 2008;198: 1851-1855.
30. Cosma CL, Humbert O, Ramakrishnan L. Superinfecting mycobacteria home to established tuberculous granulomas. Nat Immunol 2004;5: 828-835.